A double-blind, randomized, placebo-controlled, pilot study of topiramate vs. placebo in combination with olanzapine for the prevention of weight gain in manic or mixed youth with bipolar disorder

Trial Profile

A double-blind, randomized, placebo-controlled, pilot study of topiramate vs. placebo in combination with olanzapine for the prevention of weight gain in manic or mixed youth with bipolar disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2013

At a glance

  • Drugs Topiramate (Primary) ; Olanzapine
  • Indications Bipolar I disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Jul 2008 The expected completion date for this trial is now 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top